Literature DB >> 2369637

In vivo administration of antibody to interleukin-5 inhibits increased generation of eosinophils and their progenitors in bone marrow of parasitized mice.

D M Rennick1, L Thompson-Snipes, R L Coffman, B W Seymour, J D Jackson, S Hudak.   

Abstract

Bone marrow of mice parasitized with Nippostrongylus brasiliensis showed increased numbers of eosinophils as early as 4 days after infection. By day 7, their bone marrow also contained elevated numbers of progenitors that form small eosinophil colonies (20 to 50 cells) in soft agar cultures supplemented with interleukin-5 (IL-5). However, when mice were infused with anti-IL-5 antibodies at the time of infection, the number of recognizable eosinophils present in bone marrow remained low and eventually dropped below normal levels. The antibody treatment also prevented increased generation of IL-5-responsive precursors capable of differentiating into mature eosinophils in liquid culture and inhibited the generation of progenitor cells capable of forming small eosinophil colonies or clusters in soft agar cultures. The results of these in vivo experiments directly show that IL-5 is an essential regulatory molecule required for the bone marrow-dependent phase of a parasite-induced eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2369637

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Partial cross-resistance between Strongyloides venezuelensis and Nippostrongylus brasiliensis in rats.

Authors:  B K Baek; M K Islam; J H Kim; J W Lee; J Hur
Journal:  Korean J Parasitol       Date:  1999-06       Impact factor: 1.341

2.  Eosinophil and IgE responses of IL-5 transgenic mice experimentally infected with Nippostrongylus brasiliensis.

Authors:  J Y Chai; E H Shin; K Takatsu; N Matsumoto; S Kojima
Journal:  Korean J Parasitol       Date:  1999-06       Impact factor: 1.341

3.  Interleukin-5 reduces the expression of uteroglobin-related protein (UGRP) 1 gene in allergic airway inflammation.

Authors:  Yoshihiko Chiba; Achara Srisodsai; Porntip Supavilai; Shioko Kimura
Journal:  Immunol Lett       Date:  2005-02-15       Impact factor: 3.685

4.  Interleukin-5 is necessary for eosinophilia induced by cyclophosphamide in immunized mice.

Authors:  H H Mu; R Penny; W A Sewell
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

5.  Cytokine regulation of murine leishmaniasis: interleukin 4 is not sufficient to mediate progressive disease in resistant C57BL/6 mice.

Authors:  M D Sadick; N Street; T R Mosmann; R M Locksley
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

6.  Hypofibrinogenemia due to fibrin formation in subserosal type eosinophilic gastroenteropathy.

Authors:  E Presterl; L Wagner; W Base
Journal:  Clin Investig       Date:  1992-06

7.  Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels.

Authors:  Miguel L Stein; Joyce M Villanueva; Bridget K Buckmeier; Yoshiyuki Yamada; Alexandra H Filipovich; Amal H Assa'ad; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2008-04-14       Impact factor: 10.793

8.  Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis.

Authors:  A P Limaye; J S Abrams; J E Silver; K Awadzi; H F Francis; E A Ottesen; T B Nutman
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

Review 9.  Immunity to the model intestinal helminth parasite Heligmosomoides polygyrus.

Authors:  Lisa A Reynolds; Kara J Filbey; Rick M Maizels
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

10.  IL-5 drives eosinophils from bone marrow to blood and tissues in a guinea-pig model of visceral larva migrans syndrome.

Authors:  L H Faccioli; V F Mokwa; C L Silva; G M Rocha; J I Araujo; M A Nahori; B B Vargaftig
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.